Santarus says FDA will review OTC Zegerid by Dec.
Posted by Mary Canady on June 23 2009
No Comments
Santarus Inc. said Tuesday the proposed over-the-counter version of the heartburn drug Zegerid will be reviewed by the Food and Drug Administration by December.
See other entries categorized in News, San Diego Union Tribune, Syndication.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
Print This Post
.
Subscribe by RSS or email. Connect with San Diego Biotech professionals by joining the SDBN and attending our next event.
